Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Belcan is a global provider of engineering, supply chain, technical recruiting, and IT services, with a specialized division dedicated to the life sciences and healthcare sectors. The company provides end-to-end engineering solutions, regulatory compliance consulting, and quality management systems for medical device, pharmaceutical, and biotechnology manufacturers. Their services include product design, process validation, manufacturing engineering, and technical staffing to help healthcare companies navigate complex regulatory environments and accelerate time-to-market. In 2024, Belcan was acquired by Cognizant for approximately $1.3 billion, integrating its deep domain expertise into Cognizant's broader engineering research and development (ER&D) portfolio. The company continues to support global healthcare organizations in their digital transformation and technical operational needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Belcan.